Overview:
At The AI Summit New York City in December 2025, leaders in medicine and creative strategy explored how artificial intelligence can strengthen human systems rather than replace them. Featuring insights from pediatric heart transplant surgeon and healthtech investor Timothy Martens and creative systems strategist Charlie Guyer, this Presence News report examines how AI is being deployed to close care gaps, restore patient-provider trust, and support human-led innovation across complex institutions.
In early December, Presence News attended The AI Summit New York City, held at the Javits Center, where global leaders in healthcare, technology, and innovation convened to examine how artificial intelligence is reshaping critical human systems. Among the most consequential conversations were two panels held on December 9, 2025, each addressing a core tension of the AI era: how advanced technology can enhance—rather than replace—human judgment, trust, and creativity.
Two speakers stood out for articulating this balance across distinct but interconnected domains: Dr. Timothy Martens, a surgeon-investor working at the frontier of pediatric medicine and AI-assisted care delivery, and Charlie Guyer, a strategist focused on human-led innovation within complex creative systems.
Together, their insights form a compelling framework for how AI can be responsibly integrated into society’s most sensitive institutions.
Re-Humanizing Medicine Through AI
Dr. Timothy Martens on Patient-Provider Connection

Speaking on the panel “The Human Touch: Can AI Restore Meaningful Patient-Provider Connections?”, Dr. Timothy Martens offered a perspective grounded in daily clinical reality rather than abstraction.
Dr. Martens serves as Surgical Director of Pediatric Heart Transplant at Northwell Health, where he practices as a congenital cardiothoracic surgeon specializing in mechanical circulatory support, transplantation, and translational tissue engineering. His work bridges operating rooms, research laboratories, and regulatory pathways—an uncommon but increasingly vital combination in modern medicine.
Beyond clinical practice, Dr. Martens is also the Founder of Vaark Ventures and a General Partner at PhyCap Fund I, positioning him at the intersection of care delivery, technology development, and capital formation.
During the panel, Martens emphasized that AI’s most powerful contribution to medicine lies not in automation for its own sake, but in closing care gaps—particularly in complex, longitudinal conditions such as congenital heart disease.
His team is actively deploying machine-learning and AI-assisted clinical tools designed to:
- Improve consistency in care delivery
- Identify overlooked risk factors across patient populations
- Reduce administrative and cognitive burden on clinicians
- Support earlier intervention and better long-term outcomes
Crucially, Martens underscored that these tools are being designed to restore time and attention to the physician-patient relationship, not diminish it.
“Technology should remove friction from care, not empathy from medicine,” was the prevailing theme of his remarks.
His experience navigating FDA processes, directing clinical development, and working with animal models of heart disease lends credibility to a growing consensus: AI must be evaluated not just by performance metrics, but by how it reshapes trust, communication, and ethical responsibility in healthcare systems.
Creative Systems in the Age of AI
Charlie Guyer on Human-Led Innovation
On a parallel track, the panel “Creative Systems: Human-Led Innovation in the Age of AI” explored similar questions through a different lens—how organizations preserve originality, judgment, and leadership as automation scales.

Charlie Guyer, Principal and Founder of Guyer Group, brought more than two decades of executive-level experience across enterprise technology, agency environments, and venture-backed startups.
His career includes senior roles at global firms such as Cisco and Alcatel-Lucent, where he worked on large-scale systems that demanded both technical precision and human coordination.
Guyer’s central argument was clear: AI is most effective when embedded within well-designed creative systems—systems that remain accountable to human leadership.
Rather than viewing AI as a replacement for creative or strategic work, Guyer framed it as:
- An amplifier of insight
- A pattern-recognition engine
- A decision-support layer within human-directed processes
He warned against delegating judgment prematurely to automated systems, particularly in branding, communications, and organizational strategy—fields where context, narrative, and ethical nuance remain deeply human responsibilities.
Guyer’s academic background—an M.S. in Marketing Communications from Boston University and a B.S. in English from University of New Hampshire—informs a philosophy that places language, meaning, and interpretation at the center of technological adoption.
A Shared Framework: AI as Infrastructure, Humans as Stewards
Though speaking in different panels, Martens and Guyer converged on a shared principle:
AI should function as infrastructure—not authority.
In medicine, this means AI supports clinicians so they can practice more humanely and consistently.
In creative and organizational systems, it means AI enhances clarity and efficiency without eroding authorship or accountability.
Both speakers rejected the narrative of inevitable human displacement. Instead, they presented a model of co-evolution, where technology matures alongside professional ethics, institutional governance, and public trust.
Why These Conversations Matter
As AI rapidly enters regulated domains—healthcare, finance, communications, and public institutions—the frameworks discussed on December 9, 2025, at The AI Summit New York City offer durable reference points for policymakers, technologists, and educators.
The takeaway is not that AI must be slowed—but that it must be designed with intention, evaluated with humility, and deployed in service of human connection.
For Presence News, these discussions represent more than conference commentary. They mark an emerging consensus among practitioners working at the highest levels of complexity:
The future of AI will be judged not by its intelligence, but by the quality of the human systems it strengthens.

